Gene Solutions is a global biotechnology company headquartered in Singapore with a mission to make advanced genomic solutions accessible and affordable. Leveraging multi-omics, NGS, and AI, the company offers a portfolio including multicancer early detection (SPOT-MAS) and comprehensive tumor profiling with ctDNA monitoring (K-TRACK, K-4CARE). Gene Solutions operates CAP-accredited NGS laboratories and has delivered millions of genetic tests worldwide since 2017. For more information, visit www.genesolutions.com and follow the company on LinkedIn and Facebook.

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

For more information, please visit www.msd.com

NovogeneAIT Genomics is a leading multi-omics services and solutions provider headquartered in Singapore. It is formed as a strategic joint venture between Novogene and AITbiotech, a Singapore biotech Company in 2016. With an unwavering commitment to delivering high-quality, swift, and cost-effective omics solutions, NovogeneAIT Genomics has grown to become one of the largest NGS service providers in Southeast Asia. It offers a comprehensive suite of multi-omics services encompasses genomics, transcriptomics, single cell/spatial transcriptomics, metagenomics, and proteomics. Operating from our state-of-the-art sequencing center in Singapore, NovogeneAIT is dedicated to advancing genomic research by offering unmatched data quality that empowers researchers across diverse sectors, including healthcare and agriculture, to realize their research goals. For more information, visit www.novogene.com/amea-en/

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. With a strong foundation in molecular biology, Promega enables researchers, clinicians, and diagnostic developers to generate reliable, high-quality data from discovery to clinical application. Promega’s portfolio supports key areas of clinical and translational research, including molecular oncology, molecular diagnostics, diagnostic assay development, and clinical assay development services.

In addition to its off-the-shelf solutions, Promega partners with diagnostic and biotechnology organizations through custom and OEM services, supporting assay development and commercialization from concept to market. With cGMP manufacturing, ISO-certified quality systems, and in-house production of the majority of its reagents, Promega delivers scalable, custom formulations, components, and private-label solutions for clinical and molecular diagnostic applications. Together, these capabilities support applications across DNA and RNA analysis, therapeutic development, infectious diseases, and One Health—turning discovery into clinical impact.

Find out more: https://www.promega.sg/

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist manufactures synthetic DNA-based products, including synthetic genes, tools for NGS preparation, and antibody libraries for drug discovery and development.

Find out more here: https://www.twistbioscience.com/